Encyclopedia of Autism Spectrum Disorders

Living Edition
| Editors: Fred R. Volkmar

Medical Evaluation in Autism

  • Jessica L. RoesserEmail author
Living reference work entry
DOI: https://doi.org/10.1007/978-1-4614-6435-8_32-3


All children diagnosed with an autism spectrum disorder should have an evaluation by a medical professional to consider the potential causes of developmental disability and evaluate the individual for common co-occurring medical conditions. The medical evaluation includes a thorough medical history including family history, physical examination, and neurological examination. Consideration of genetic causes requires laboratory testing most commonly using chromosomal microarray if no specific syndrome requires workup. Other genetic screening tests might include testing for X-linked intellectual disability, Rett syndrome, or other diagnoses suggested by the history and physical examination.

Historical Background

In 1941, Dr. Leo Kanner first described autism as a discrete disorder. Around the same time, Dr. Hans Asperger identified a similar disorder in Germany. While a similarity to childhood schizophrenia led many to consider autism a psychiatric disorder, Dr. Bruno...

This is a preview of subscription content, log in to check access.

References and Reading

  1. Ferguson, B. J., Marler, S., Altstein, L. L., Lee, E. B., Akers, J., Sohl, K., McLaughlin, A., Hartnett, K., Kille, B., Mazurek, M., Macklin, E. A., McDonnell, E., Barstow, M., Bauman, M. L., Margolis, K. G., Veenstra-VanderWeele, J., & Beversdorf, D. Q. (2017). Psychophysiological associations with gastrointestinal symptomatology in autism spectrum disorder. Autism Research, 10(2), 276–288.  https://doi.org/10.1002/aur.1646. Epub 2016 Jun 20. PMID:27321113.CrossRefPubMedGoogle Scholar
  2. Johnson, C. P., Myers, S. M., & American Academy of Pediatrics, Council on Children with Disabilities. (2007). Identification and evaluation of children with autism spectrum disorder. Pediatrics, 120(5), 1183–1215.CrossRefGoogle Scholar
  3. Lo, S. (2011). Laboratory testing in infants and children. In M. Kleigman (Ed.), Nelson textbook of pediatrics (19th ed.). Philadelphia: Saunders. Chapter 707.Google Scholar
  4. Mazurek, M. O., & Petroski, G. F. (2015). Sleep problems in children with autism spectrum disorder: Examining the contributions of sensory over-responsivity and anxiety. Sleep Medicine, 16(2), 270–279.  https://doi.org/10.1016/j.sleep.2014.11.006. Epub 2014 Nov 28.CrossRefPubMedGoogle Scholar
  5. Miller, D. T., Adam, M. P., Aradhya, S., Bisecker, L. G., Brothman, A. R., Carter, N. P., et al. (2010). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics, 86, 749–764.CrossRefGoogle Scholar
  6. Myers, S. M., Johnson, C. P., & American Academy of Pediatrics, Council on Children with Disabilities. (2007). Management of children with autism spectrum disorders. Pediatrics, 120(5), 1162–1182.CrossRefGoogle Scholar
  7. Payakachat, N., Tilford, J. M., & Ungar, W. J. (2016). National Database for Autism Research (NDAR): Big data opportunities for health services research and health technology assessment. Pharmaco Economics, 34(2), 127–138.  https://doi.org/10.1007/s40273-015-0331-6.CrossRefGoogle Scholar
  8. Roesser, J. (2011). Diagnostic yield of genetic testing in children diagnosed with autism spectrum disorders at a regional referral center. Clinical Pediatrics, 50(9), 834–843.CrossRefGoogle Scholar
  9. Schaefer, G. B., & Mendelsohn, N. J. (2008). Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genetics in Medicine, 10, 301.CrossRefGoogle Scholar
  10. Shen, Y., Dies, K. A., Holm, I. A., Bridgemohan, C., Sobeih, M. M., Caronna, E. B., et al. (2010). Clinical genetic testing for patients with autism spectrum disorders. Pediatrics, 125, e727.CrossRefGoogle Scholar
  11. Tammimies, K., Marshall, C. R., Walker, S., Kaur, G., Thiruvahindrapuram, B., Lionel, A. C., Yuen, R. K., Uddin, M., Roberts, W., Weksberg, R., Woodbury-Smith, M., Zwaigenbaum, L., Anagnostou, E., Wang, Z., Wei, J., Howe, J. L., Gazzellone, M. J., Lau, L., Sung, W. W., Whitten, K., Vardy, C., Crosbie, V., Tsang, B., D’Abate, L., Tong, W. W., Luscombe, S., Doyle, T., Carter, M. T., Szatmari, P., Stuckless, S., Merico, D., Stavropoulos, D. J., Scherer, S. W., & Fernandez, B. A. (2015). Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder. JAMA, 314(9), 895–903.  https://doi.org/10.1001/jama.2015.10078.CrossRefPubMedGoogle Scholar
  12. Weinstein, V., Tanpaiboon, P., Chapman, K. A., Ah Mew, N., & Hofherr, S. (2017). Do the data really support ordering fragile X testing as a first-tier test without clinical features? Genetics in Medicine.  https://doi.org/10.1038/gim.2017.64.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2018

Authors and Affiliations

  1. 1.Department of Pediatrics (SMD)University of Rochester, School of Medicine and DentistryRochesterUSA